Total investment of 29 million euros for Merck to expand the Shanghai Biosafety Testing and Experimental Center
博阿尔农
发表于 2023-11-21 18:10:20
1303
0
0
Southern Finance and Economics, November 21 (Xinhua) - Merck announced today that the second phase of its China Biosafety Testing and Experimental Center project, which was built with a total investment of 29 million euros last year, has been successfully completed and officially put into use, adding an additional 1500 square meters to the first phase of last year's project. This testing and experimental center is Merck's first biosafety testing and experimental facility in the Chinese market. (21st Century Economic Report)
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Google wins EU advertising antitrust case, court withdraws 1.49 billion euros fine
- What does Apple's first public Shanghai Application Research Laboratory mean for iPhone 16?
- The new iPhone is on sale today, and there is a long queue in Beijing and Shanghai! The entry-level model has been "cracked" and "scalpers" have collected the Pro Max on site, and reselling it can earn hundreds of yuan
- Conglian Group: Shanghai's niche chip company breaks through with cryptocurrency
- Tianjing Biotechnology and Sanofi have reached an authorization agreement with a potential total price of up to 200 million euros
- Tesla Shanghai Gigafactory exports over 1 million vehicles
- JD Qixian Supermarket's first trial store in Shanghai has an average daily customer flow of over 10000 people
- Tesla's Shanghai Gigafactory's 3 millionth vehicle officially goes offline
- ASML's net sales for the third quarter were 7.5 billion euros, but new orders were lower than expected, putting pressure on the stock price
- Establishing a green channel for high-quality brands, Vipshop is seeking gold at the Shanghai International Import Expo
-
【英偉達の需要が高すぎる?SKハイニックス:黄仁勲がHBM 4チップの6カ月前納入を要求!】SKハイニックスの崔泰源(チェ・テウォン)会長は月曜日、インビダーの黄仁勲(ファン・インフン)CEOが同社の次世代高帯域 ...
- 琳271
- 昨天 17:54
- 支持
- 反对
- 回复
- 收藏
-
ファイザーが前立腺がんを治療する革新薬テゼナ& ;reg;(TALZENNA®,一般名:トルエンスルホン酸タラゾールパーリカプセル)は2024年10月29日に国家薬品監督管理局(NMPA)の承認を得て、HRR遺伝子突然変異 ...
- 什么大师特
- 3 小时前
- 支持
- 反对
- 回复
- 收藏
-
南方財経は11月5日、中央テレビのニュースによると、現地時間11月5日、米ボーイング社のストライキ労働者が59%の投票結果で新たな賃金協定を受け入れ、7週間にわたるストライキを終えた。ストライキ労働者は11月12 ...
- Dubssgshbsbdhd
- 5 小时前
- 支持
- 反对
- 回复
- 收藏
-
【マスクはテスラが携帯電話を作ることに応えた:作れるが作らないアップルとグーグルが悪さをしない限り】現地時間11月5日、有名ポッドキャストのジョローガン氏のインタビューに応じ、「携帯電話を作るのは私たち ...
- 波大老师
- 6 小时前
- 支持
- 反对
- 回复
- 收藏